A Study to Evaluate Safety and Tolerability of BPT567 in Patients With Advanced Solid Tumors

NCT06779851 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

20

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Advanced Solid Tumors

Interventions

DRUG: BPT567

Sponsor

Bright Peak Therapeutics Inc